Jab1 is a target of EGFR signaling in ERalpha-negative breast cancer

scientific article

Jab1 is a target of EGFR signaling in ERalpha-negative breast cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1007459824
P356DOI10.1186/BCR2105
P932PMC publication ID2481501
P698PubMed publication ID18534028
P5875ResearchGate publication ID5323632

P2093author name stringPeter H Watson
Nathan R West
Jiaxu Wang
Jenny E Chu
Melanie Olson
Rebecca O Barnes
P2860cites workS100A7 and the progression of breast cancerQ22000741
Psoriasin (S100A7) expression and invasive breast cancerQ22010926
Psoriasin expression in mammary epithelial cells in vitro and in vivoQ24292122
A putative role for psoriasin in breast tumor progressionQ24298889
A new group of conserved coactivators that increase the specificity of AP-1 transcription factorsQ24310680
Jab1 antagonizes TGF-beta signaling by inducing Smad4 degradationQ24522552
COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin systemQ24545648
Gene expression signature of estrogen receptor alpha status in breast cancerQ24805289
S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breastQ24805971
Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1Q28138425
JAB1 interacts with both the progesterone receptor and SRC-1Q28139007
Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1Q28139243
COP9 signalosome-directed c-Jun activation/stabilization is independent of JNKQ28139466
Integrin LFA-1 interacts with the transcriptional co-activator JAB1 to modulate AP-1 activityQ28141877
Psoriasin interacts with Jab1 and influences breast cancer progressionQ28191754
The cytoplasmic shuttling and subsequent degradation of p27Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complexQ28204773
Jab1 interacts directly with HIF-1alpha and regulates its stabilityQ28205085
Clustered organization of S100 genes in human and mouseQ28295343
HER2-targeting antibodies modulate the cyclin-dependent kinase inhibitor p27Kip1 via multiple signaling pathwaysQ28299421
Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in MCF-7 breast cancer cellsQ30438933
JAB1/CSN5 interacts with the GAL4 DNA binding domain: a note of caution about two-hybrid interactionsQ30772126
A SAGE (serial analysis of gene expression) view of breast tumor progression.Q30998378
The Clinical Significance of Epidermal Growth Factor Receptor (EGF-R) in Human Breast Cancer: A Review on 5232 Patients*Q33188817
S100A7-downregulation inhibits epidermal growth factor-induced signaling in breast cancer cells and blocks osteoclast formationQ33322536
The nuclear factor kappa B (NF-kappa B): a potential therapeutic target for estrogen receptor negative breast cancersQ33943227
Studies of epidermal growth factor receptor inhibition in breast cancerQ34376342
Genetic regulators of large-scale transcriptional signatures in cancerQ34537800
Predicting a local recurrence after breast-conserving therapy by gene expression profilingQ35605850
NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosisQ35971557
Clinical value of epidermal growth factor receptor expression in primary breast cancerQ36279731
Linkage between EGFR family receptors and nuclear factor kappaB (NF-kappaB) signaling in breast cancerQ36604000
C-myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevanceQ36621638
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancerQ36678853
Inductive mechanisms limiting response to anti-epidermal growth factor receptor therapy.Q36720713
CSN5 isopeptidase activity links COP9 signalosome activation to breast cancer progressionQ37106255
Jab1 is overexpressed in human breast cancer and is a downstream target for HER-2/neu.Q40017171
The S100A7-c-Jun activation domain binding protein 1 pathway enhances prosurvival pathways in breast cancerQ40402282
Akt-dependent T198 phosphorylation of cyclin-dependent kinase inhibitor p27kip1 in breast cancer.Q40530643
Predicting continuous values of prognostic markers in breast cancer from microarray gene expression profiles.Q40585484
Oestrogen receptor-mediated modulation of the EGFR/MAPK pathway in tamoxifen-resistant MCF-7 cells.Q40628338
The epidermal growth factor receptor as a prognostic marker: results of 370 patients and review of 3009 patientsQ40665439
PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrestQ40702262
c-myc oncogene expression in estrogen-dependent and -independent breast cancerQ40875264
Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancerQ41090487
The constitutive photomorphogenesis 9 signalosome directs vascular endothelial growth factor production in tumor cells.Q42513620
Psoriasin (S100A7) expression is associated with poor outcome in estrogen receptor-negative invasive breast cancerQ44509716
Jun activation domain binding protein 1 expression is associated with low p27(Kip1)levels in node-negative breast cancer.Q47343720
EGF-R and steroid receptors in breast cancer: a comparison with tumor grading, tumor size, lymph node involvement, and age.Q47392457
HER-2 amplification, steroid receptors and epidermal growth factor receptor in primary breast cancerQ61853774
Jun activation domain-binding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27(Kip1)Q64377657
Epidermal growth factor receptor and other oncogenes as prognostic markersQ68201105
Refined mapping of the psoriasin gene S100A7 to chromosome 1cen-q21Q70807777
Differential expression of psoriasin messenger RNA between in situ and invasive human breast carcinomaQ71614084
Prognostic value of epidermal growth factor receptor (EGFR) and its relationship to the estrogen receptor status in 1029 patients with breast cancerQ77673978
P433issue3
P304page(s)R51
P577publication date2008-06-06
P1433published inBreast Cancer ResearchQ2208481
P1476titleJab1 is a target of EGFR signaling in ERalpha-negative breast cancer
P478volume10

Reverse relations

cites work (P2860)
Q39555290Bezielle (BZL101)-induced oxidative stress damage followed by redistribution of metabolic fluxes in breast cancer cells: a combined proteomic and metabolomic study
Q24315611COP9-associated CSN5 regulates exosomal protein deubiquitination and sorting
Q37063329COPS5 amplification and overexpression confers tamoxifen-resistance in ERα-positive breast cancer by degradation of NCoR.
Q90330859CSN5 controls the growth of osteosarcoma via modulating the EGFR/PI3K/Akt axis
Q24319983Dynamic regulation of the COP9 signalosome in response to DNA damage
Q39766695High-throughput profiling of tissue and tissue model microarrays: Combined transmitted light and 3-color fluorescence digital pathology.
Q47153479Increased Jab1/COPS5 is associated with therapeutic response and adverse outcome in lung cancer and breast cancer patients
Q38708092Inhibiting epidermal growth factor receptor signalling potentiates mesenchymal-epithelial transition of breast cancer stem cells and their responsiveness to anticancer drugs
Q34292695JAB1/CSN5: a new player in cell cycle control and cancer
Q52657204Jab1/COPS5 as a Novel Biomarker for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Human Cancer.
Q39623720Psoriasin (S100A7) associates with integrin β6 subunit and is required for αvβ6-dependent carcinoma cell invasion.
Q34180715Regulation of the human catalytic subunit of telomerase (hTERT).
Q39747948S100A7 (psoriasin) is induced by the proinflammatory cytokines oncostatin-M and interleukin-6 in human breast cancer.
Q36327912Targeting Jab1/CSN5 in nasopharyngeal carcinoma
Q26782011The Role of the COP9 Signalosome and Neddylation in DNA Damage Signaling and Repair

Search more.